Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The . gov means it’s official. Federal government websites often end in . gov or . mil VSports app下载. Before sharing sensitive information, make sure you’re on a federal government site. .

Https

The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely. V体育官网.

Review
. 2016 Mar 18;118(6):1021-40.
doi: 10.1161/CIRCRESAHA.115.306565.

Cardiac Fibrosis: The Fibroblast Awakens

Joshua G Travers  1 , Fadia A Kamal  1 , Jeffrey Robbins  1 , Katherine E Yutzey  1 , Burns C Blaxall  2
Affiliations
Review

Cardiac Fibrosis: The Fibroblast Awakens

Joshua G Travers et al. Circ Res. .

Abstract

Myocardial fibrosis is a significant global health problem associated with nearly all forms of heart disease. Cardiac fibroblasts comprise an essential cell type in the heart that is responsible for the homeostasis of the extracellular matrix; however, upon injury, these cells transform to a myofibroblast phenotype and contribute to cardiac fibrosis. This remodeling involves pathological changes that include chamber dilation, cardiomyocyte hypertrophy and apoptosis, and ultimately leads to the progression to heart failure. Despite the critical importance of fibrosis in cardiovascular disease, our limited understanding of the cardiac fibroblast impedes the development of potential therapies that effectively target this cell type and its pathological contribution to disease progression. This review summarizes current knowledge regarding the origins and roles of fibroblasts, mediators and signaling pathways known to influence fibroblast function after myocardial injury, as well as novel therapeutic strategies under investigation to attenuate cardiac fibrosis VSports手机版. .

Keywords: disease progression; extracellular matrix; fibroblasts; fibrosis; heart failure; therapeutics. V体育安卓版.

PubMed Disclaimer

"V体育2025版" Figures

Figure 1
Figure 1. Characteristics and Functions of Activated Cardiac MFs
Cardiac fibroblasts respond to pathologic stress and environmental stimuli by transforming into MFs that (1) express elevated levels of various pro-inflammatory and pro-fibrotic factors that directly contribute to inflammatory cell infiltration and fibroblast proliferation, (2) secrete high levels of matrix metalloproteinases and other ECM degrading enzymes that facilitate fibroblast migration and (3) contribute to the deposition of collagen and other ECM proteins leading to scar formation. While this adaptive fibrotic scar tissue maintains the structural integrity and pressure generating capacity of the heart, MF persistence eventually leads to the development of adverse changes in ventricular structure and compliance, leading to the progression to heart failure.
Figure 2
Figure 2. Proposed Sources of Cardiac MFs
The source(s) of activated CFs that accumulate in response to various pathological insults remains under active investigation. Mounting evidence suggests that activated MFs in the fibrotic heart derive from the proliferation and activation of resident fibroblasts, as these cells are remarkably sensitive to pathologic insult and represent a feasible source of matrix-producing cells during cardiac fibrosis. Numerous additional precursors to the fibroblast population in the injured heart have been proposed; these include endothelial and epicardial cells, through EMT and EndMT, respectively, hematopoietic bone marrow-derived cells, perivascular cells and fibrocytes. While supporting evidence exists for cellular sources of activated fibroblasts denoted by question marks, controversy remains regarding the functional contribution of these cell types to the cardiac MF population. Biomarkers with greater specificity will be required to fully characterize the pathophysiologic relevance of these cell types in the cardiac fibrotic response, which will enable potential targeting for anti-fibrotic therapies.
Figure 3
Figure 3. Selection of Signaling Pathways Regulating MF Activation and Potential Therapeutic Targets for Cardiac Fibrosis
Numerous signaling pathways have been implicated in the activation of cardiac fibroblasts and the induction of pathological remodeling; targeting these signals is of intense scientific interest toward development of novel therapeutic strategies. Cardiac injury promotes the activation of receptors such as the β-AR, ALK5, AT1R, ETR, TRPC6 and Integrins, which induces pathologic signaling through numerous mediators, leading to the transcription of factors that regulate MF activation and fibrotic remodeling. Proposed antifibrotic therapeutic targets are marked with a red X. (β-AR: β-adrenergic receptor, AC: adenylate cyclase, TRPC6: transient receptor potential channel C6, AT1R: type 1 angiotensin II receptor, ETR: endothelin receptor: TGF-β: transforming growth factor β, LTBP: latent TGF-β binding protein, ALK5: activin receptor-like kinase 5 / TGF-β receptor, GRK2: g protein-coupled receptor kinase 2, ERK1/2: extracellular regulated kinase 1/2, MEK1: mitogen activated protein kinase kinase 1, NFAT: nuclear factor of activated T-cells, MRTF: myocardin-related transcription factor, TAK1: TGF-β – activated kinase 1, JNK: c-JUN N-terminal kinase, PI3K: phosphoinositide 3-kinase).
See this image and copyright information in PMC

"V体育官网入口" References

    1. Mozaffarian D, Benjamin EJ, Go AS, Arnett DK, Blaha MJ, Cushman M, de Ferranti S, Despres JP, Fullerton HJ, Howard VJ, Huffman MD, Judd SE, Kissela BM, Lackland DT, Lichtman JH, Lisabeth LD, Liu SM, Mackey RH, Matchar DB, McGuire DK, Mohler ER, Moy CS, Muntner P, Mussolino ME, Nasir K, Neumar RW, Nichol G, Palaniappan L, Pandey DK, Reeves MJ, Rodriguez CJ, Sorlie PD, Stein J, Towfighi A, Turan TN, Virani SS, Willey JZ, Woo D, Yeh RW, Turner MB, Comm AHAS, Subcomm SS. Heart disease and stroke statistics-2015 update a report from the american heart association. Circulation. 2015;131:E29–E322. - "VSports注册入口" PubMed
    1. Ali SR, Ranjbarvaziri S, Talkhabi M, Zhao P, Subat A, Hojjat A, Kamran P, Muller AMS, Volz KS, Tang ZY, Red-Horse K, Ardehali R. Developmental heterogeneity of cardiac fibroblasts does not predict pathological proliferation and activation. Circ Res. 2014;115:625–U681. - VSports - PubMed
    1. Mikawa T, Gourdie RG. Pericardial mesoderm generates a population of coronary smooth muscle cells migrating into the heart along with ingrowth of the epicardial organ. Dev Biol. 1996;174:221–232. - PubMed
    1. Moore-Morris T, Guimaraes-Camboa N, Banerjee I, Zambon AC, Kisseleva T, Velayoudon A, Stallcup WB, Gu YS, Dalton ND, Cedenilla M, Gomez-Amaro R, Zhou B, Brenner DA, Peterson KL, Chen J, Evans SM. Resident fibroblast lineages mediate pressure overload-induced cardiac fibrosis. J Clin Invest. 2014;124:2921–2934. - PMC - PubMed
    1. Krenning G, Zeisberg EM, Kalluri R. The origin of fibroblasts and mechanism of cardiac fibrosis. Journal of cellular physiology. 2010;225:631–637. - PMC - PubMed

Publication types

MeSH terms

Substances